Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antitumor effect of levamisole]

G Hisano, K Yata, E Tsubura

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |July 1, 1982
    PubMed
    Summary

    Levamisole treatment inhibited mouse tumor growth by activating spleen macrophages. These activated macrophages appear to be the primary mechanism behind levamisole's anti-tumor effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Submental island flap reconstruction in oral cavity cancer patients with level I lymph node metastasis.

    The British journal of oral & maxillofacial surgery·2016
    Same author

    CD138-negative clonogenic cells are plasma cells but not B cells in some multiple myeloma patients.

    Leukemia·2012
    Same author

    The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.

    Leukemia·2011
    Same author

    Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells.

    British journal of haematology·2004
    Same author

    The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells.

    Leukemia·2004
    Same author

    Filter cigarette smoking and lung cancer risk; a hospital-based case--control study in Japan.

    British journal of cancer·2004

    Area of Science:

    • Immunology
    • Oncology
    • Pharmacology

    Context:

    • MH134 tumor models in C3H mice are used to study anti-cancer drug efficacy.
    • Levamisole is an anthelmintic drug with known immunomodulatory properties.
    • Tumor growth inhibition is a key indicator of potential anti-cancer therapies.

    Purpose:

    • To investigate the anti-tumor effects of levamisole on MH134 tumor growth in mice.
    • To elucidate the cellular mechanisms underlying levamisole-induced tumor inhibition.
    • To determine the role of spleen cells, particularly macrophages, in levamisole's anti-cancer activity.

    Summary:

    • Levamisole treatment significantly inhibited the growth of transplanted MH134 tumors in the footpads of C3H mice.
    • Studies involving the transfer of spleen cells from treated mice suggested an immune-mediated mechanism.
    • Evidence points to activated macrophages within the spleen cell population as the key mediators responsible for the observed tumor growth inhibition.

    Impact:

    • This study highlights levamisole's potential as an immunotherapeutic agent for cancer treatment.
    • Understanding the role of macrophage activation provides insights into novel anti-cancer strategies.
    • The findings could pave the way for developing new therapies that harness the immune system to combat tumors.

    Related Experiment Videos